nanochannels

In 2017, Bionano had $9.5 million in revenues and a net loss of 23.4 million, or $7.66 per share.

With its Direct Labeling and Staining (DLS) chemistry, currently available to early-access users, Bionano is pushing forward with more contiguous genome maps.

BioNano Genomics has launched its nanochannel-based single-molecule DNA mapping platform in Europe and plans to extend the technology to human-size genomes later this year, enabling researchers to discover new structural variants, separate haplotypes, and obtain better genome ass

BioNanomatrix has changed its name to BioNano Genomics, the company said this week.
Through the name change, the firm wants to communicate "its position as a solution provider for genomics researchers."

The Philadelphia-based Princeton University spinout plans to use $830,000 in new supplemental grant funding from the National Human Genome Research Institute to prepare for beta-testing of its NanoAnalyzer next year.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.